Hanmi and Hanlim to win patent suit against Cipla, protecting their complexes

Hanmi Pharm and Hanlim Pharm won a patent suit against an Indian generic company, ‘Cipla.’

Conclusion of the suit has urgently attracted the industry since it was related to Hanmi Pharm and Hanmil Pharm’s self-developed allergy rhinitis complex drugs launched in 2013, ‘Motesoneplus Nasal Spray’ and ‘Nasaflex Nasal Spray.’

According to the pharmaceutical industry on the 2^nd, the Intellectual ...